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For decades, prospective randomized 
clinical trials (RCTs) have been the 
“gold standard” for medical research. 
These studies randomly assign patients 
to one of two groups: half receive 
the standard treatment, and half 
undergo the experimental approach. 
As Associate Professor of Surgery 
Harish Lavu, MD, FACS, explains, 
randomly assigning patients helps 
eliminate even subconscious bias 
on the part of researchers. Dr. Lavu 
notes that while there is widespread 
agreement that RCTs are the best way 
to conduct research, these studies are 
complex and often costly. Funding 
often comes from institutional sources, 
government sponsored research grants, 
philanthropic organizations,  
or pharmaceutical companies.
“From conception to completion, 
a high-quality prospective RCT can 
take two to 10 years. By contrast, 
retrospective studies – in which 
researchers analyze an existing data 
set, such as a large collection of patient 
charts – are typically much faster and 
easier,” Dr. Lavu says. He adds that 
while retrospective studies can provide 
early findings suggesting that a new 
method may be beneficial or merits 
further investigation, the gold standard 
to test the hypothesis is often a full-
scale RCT.
Jefferson’s Department of Surgery has 
a number of RCTs in various stages  –  
including the HYSLAR (Hypertonic 
Saline) Trial and the Celiac Nerve Block 
trial for pancreatic cancer patients as 
well as a trial analyzing sternal pain 
after cardiac surgery.
The 264-patient HYSLAR Trial stud-
ied the type of fluid used during the 
Whipple procedure (pancreaticoduode-
nectomy). The standard approach  
is to administer Lactated Ringer’s  
solution for fluid replacement. The 
study hypothesized that with a more 
concentrated saline, surgeons could 
administer less fluid and improve 
outcomes.
“In our trial, surgeons used the standard 
amount of Lactated Ringer’s solution 
with half of the patients, while the 
other half received the concentrated 
form of intravenous fluids known as 
hypertonic saline,” he says. “We found 
that with hypertonic saline, we were 
able to get patients through surgery 
and the recovery period with less total 
fluid administered. In fact, reducing 
fluid by several liters resulted in a 
25-percent reduction in post-surgical 
complications such as edema and fluid 
build up in the lungs.” Dr. Lavu and 
colleagues published the results in the 
September issue of Annals of Surgery.
From 2008 to 2013, Jefferson also 
enrolled pancreatic cancer patients in 
the Celiac Nerve Block Trial. All told, 
485 individuals enrolled and have 
been helping researchers understand 
whether or not injecting concentrated 
ethanol into the celiac nerve during 
surgery lessens severe abdominal pain 
and improves quality of life. 
“This is a double-blind placebo-
controlled trial – meaning that neither 
the researchers nor the patients know 
who has received the ethanol nerve 
block and who has received the saline 
as a placebo,” Dr. Lavu says. “We are 
currently analyzing the data and look 
forward to presenting our findings in 
December at the Annual Meeting of  
the Southern Surgical Association.”
In the Division of Cardiothoracic 
Surgery, an analysis of patients who 
underwent coronary artery bypass 
showed that compared to conventional 
sternal wire, rigid fixation using 
sternal plates led to a reduction in 
postoperative pain and shortened 
ventilation time, ICU stay and hospital 
stay. Hitoshi Hirose, MD, PhD, FACS, led 
the RCT that further investigated those 
outcomes – and confirmed a trend 
of shorter intubation time and lesser 
narcotic requirements with rigid fixation 
versus wire closure. 
These trials are just a sample of the 
gold-standard research at Jefferson.  
As Dr. Lavu notes, numerous other 
RCTs are ongoing and in development – 
including studies of vaccines and 
neoadjuvant treatment in both 
melanoma and pancreatic cancer and 
the efficacy of fibrin sealants to control 
blood loss during surgery. 
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Changing Lives Through Research
Reneé Juliano
Whether seeking an initial consultation or 
receiving post-surgical care, patients of 
Jefferson’s cardiothoracic, colon and rectal, 
general, transplant and trauma surgeons will 
see their physicians at Jefferson Hospital’s 
Medical Office Building at 11th and Walnut. A 
team of about 20 administrative professionals 
helps keep the “MOB” humming. A key part 
of that team is Practice Manager Reneé 
Juliano, who supports general surgeons 
Karen A. Chojnacki, MD, FACS, and Ernest L. 
Rosato, MD, FACS. 
Reneé joined Jefferson’s Department of 
Surgery in 1996, working in the Gibbon 
Building until the surgical practices came 
together in the MOB in 2001. She has been 
supporting Dr. Chojnacki and Dr. Rosato for 
the last 12 years – and has become a go-to 
resource for her peers. 
She enjoys helping her colleagues tackle 
everything from computer glitches to 
patient relations. To be sure, Reneé takes 
pride in assisting patients – serving as an 
administrative advocate as they schedule a 
range of procedures. When cancer patients 
are referred by other doctors, she’s the one 
who ensures that the surgeons see them 
as quickly as possible. Since Reneé isn’t 
a clinician, she doesn’t address patients’ 
medical questions. But she is quick to provide 
a listening ear and a kind word to individuals 
who are feeling anxious about their diagnosis 
or upcoming procedure.
“I get to interact with our patients every day, 
and I always try to make their situation a little 
bit better,” Reneé says. “I listen to them and 
assure them that they’re in good hands – that 
the people in our office are here to help them.”
With daily patient volume as high as 90, 
Reneé admits that the MOB can sometimes 
get hectic. Even so, she always operates by 
her own golden rule: “Treat your patients and 
co-workers the same way you’d like to be 
treated. It really does make a difference.”
“...while retrospective studies can provide 
early findings suggesting that a new 
method may be beneficial or merits further 
investigation, the gold standard to test the 
hypothesis is often a full-scale RCT.”
Drs. Hitoshi Hirose, Jordan Winter, and Harish Lavu are among the many clinician researchers in the department 
conducting radomized clinical trials to investigate and improve treatment options for their patients.
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Reneé Juliano (center) and her colleagues – including Operations Manager, Beverly Kelter (fifth  
from right) – keep the department’s 5MOB outpatient clinic at 11th and Walnut running smoothly.
1
et al.: RCTs: ‘Gold Standard’ for Medical Research Targets Improved Outcomes
Published by Jefferson Digital Commons, 2014
